Last reviewed · How we verify
Nalbuphine in superficial cervical plexus block — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Nalbuphine in superficial cervical plexus block (Nalbuphine in superficial cervical plexus block) — Kasr El Aini Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nalbuphine in superficial cervical plexus block TARGET | Nalbuphine in superficial cervical plexus block | Kasr El Aini Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nalbuphine in superficial cervical plexus block CI watch — RSS
- Nalbuphine in superficial cervical plexus block CI watch — Atom
- Nalbuphine in superficial cervical plexus block CI watch — JSON
- Nalbuphine in superficial cervical plexus block alone — RSS
Cite this brief
Drug Landscape (2026). Nalbuphine in superficial cervical plexus block — Competitive Intelligence Brief. https://druglandscape.com/ci/nalbuphine-in-superficial-cervical-plexus-block. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab